Article citationsMore>>

Totan, M., Antonescu, E., Catana, M.G., Cernusca-Mitariu, M.M., Duica, L., Roman-Filip, C., et al. (2019) C-Reactive Protein—A Predictable Biomarker in Ischemic Stroke. Revista de Chimie, 70, 2290-2293.
https://doi.org/10.37358/rc.19.6.7325

has been cited by the following article:

• TITLE: Recent Advances in the Diagnosis and Treatment of Febrile Seizures

  AUTHORS: Ya Fu, Xu Song

  KEYWORDS: Febrile Seizures, Treatment Optimization, Risk Assessment

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.8, August 15, 2025

  ABSTRACT: Febrile seizures (FS) are the most common convulsive disorders in children, occurring in children between 6 months and 5 years of age, with peak incidence between 12 and 18 months of age. The condition usually has a benign course and rarely leads to brain damage, but it can cause great psychological stress for parents—who often mistakenly believe their child is dying during a seizure. CFS and some SFS carry a risk of recurrent seizures and development of epilepsy, which may affect the child’s neurological development, cause harm to the child, and impose an mental and economic burden on parents. This article elaborates on the classification, diagnosis, optimization of treatment strategies, mechanism study and risk assessment of FS.